Showing results (51-60 of 163) with videos related to
Sort By:
Pageof 17
Nanoscale|August 24, 2018
Delivery of thrombolytic therapy using rod-shaped plant viral nanoparticles decreases the risk of hemorrhageAndrzej S Pitek, Jooneon Park, Yunmei Wang, et al.Molecular Pharmaceutics|September 8, 2017
Elongated Plant Virus-Based Nanoparticles for Enhanced Delivery of Thrombolytic TherapiesAndrzej S Pitek, Yunmei Wang, Sahil Gulati, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|February 7, 2012
Intravascular optical coherence tomography detection of atherosclerosis and inflammation in murine aortaSatoko Tahara, Toshifumi Morooka, Zhao Wang, et al.Journal of Cellular and Molecular Medicine|February 25, 2012
Up-regulation of miR-210 by vascular endothelial growth factor in ex vivo expanded CD34+ cells enhances cell-mediated angiogenesisMohamad Amer Alaiti, Masakazu Ishikawa, Haruchika Masuda, et al.Circulation|April 2, 2008
Leukocyte integrin Mac-1 promotes acute cardiac allograft rejectionKoichi Shimizu, Peter Libby, Rica Shubiki, et al.Biomacromolecules|June 1, 2021
Designing S100A9-Targeted Plant Virus Nanoparticles to Target Deep Vein ThrombosisJooneon Park, Amy M Wen, Huiyun Gao, et al.Oncotarget|May 26, 2016
Deficiency of myeloid-related proteins 8 and 14 (Mrp8/Mrp14) does not block inflammaging but prevents steatosisWilliam R Swindell, Xianying Xing, Yi Fritz, et al.Blood|May 30, 2008
Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticlesElzbieta Pluskota, Neil M Woody, Dorota Szpak, et al.Journal of the American College of Cardiology|January 5, 2005
Staged initial percutaneous coronary intervention followed by valve surgery ("hybrid approach") for patients with complex coronary and valve diseaseJohn G Byrne, Marzia Leacche, Daniel Unic, et al.Cytotherapy|November 3, 2009
Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivoMarcie R Finney, Laura R Fanning, Matthew E Joseph, et al.Pageof 17